切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - sodium channel - TAK1 - Insulin and Insulin-like Receptors - Synthases/Synthetases

13件产品中的 1-10

页面
每页
清除全部
  1. (5Z)-7-Oxozeaenol
    B7443 (5Z)-7-Oxozeaenol
     1 Citation
    Target: TAK1
    Summary: TAK1促分裂原活化蛋白激酶激酶激酶(MAPKKK)抑制剂
      <9.06 mg/mL
      insoluble in ethanol
  2. Triacsin C
    B7070 Triacsin C
    Target: Synthases/Synthetases
    Summary: 酰基辅酶A合成酶抑制剂
      Soluble in DMSO
  3. Ibutilide Fumarate
    B2278 Ibutilide Fumarate
    中文名: 富马酸伊布利特
    Target: Voltage-gated Potassium (KV) Channels|Voltage-gated Calcium Channels (CaV)|sodium channel
    Summary: III类抗心律失常药物
      ≥25.6 mg/mL
      ≥16.4 mg/mL
  4. Lamotrigine
    B2249 Lamotrigine
     1 Citation
    中文名: 拉莫三嗪
    Target: 5-HT receptors|sodium channel
    Summary: 5-HT抑制剂,钠通道阻断剂
      ≥12.3 mg/mL
      insoluble in H2O
  5. Mizoribine
    B1472 Mizoribine
    中文名: 咪唑立宾
    Target: Synthases/Synthetases
    Summary: DNA/RNA合成抑制剂
      ≥88.2 mg/mL
      ≥27.6 mg/mL
  6. GSK1838705A
    A8440 GSK1838705A
    Target: Insulin and Insulin-like Receptors|ALK
    Summary: ATP竞争性IGF-IR/IR/ALK抑制剂
      ≥26.65 mg/mL
      insoluble in H2O
  7. Oligomycin A
    A5588 Oligomycin A
     1 Citation
    中文名: 寡霉素A
    Target: Synthases/Synthetases
    Summary: 线粒体ATP合成酶抑制剂
      ≥9.89 mg/mL
      insoluble in H2O
  8. GSK1904529A
    A1302 GSK1904529A
    Target: Insulin and Insulin-like Receptors
    Summary: IGF-1R/IR 选择性抑制剂
      ≥42.6 mg/mL
      insoluble in H2O
  9. BMS-754807
    A1185 BMS-754807
    Target: Insulin and Insulin-like Receptors
    Summary: 有效的、选择性的IGF-1R和InsR抑制剂
      ≥23.05 mg/mL
      insoluble in H2O
  10. Floxuridine
    A2402 Floxuridine
    中文名: 氟尿苷
    Target: Synthases/Synthetases
    Summary: 抗肿瘤抗代谢物
      ≥12.31 mg/mL
      ≥85.5 mg/mL

13件产品中的 1-10

页面
每页